Replies to post #36534 on Biotech Values

[DewDiligence]

>Any guesses on pricing of Tyzeka? I thought I read or heard pricing will be announced this week.<

Yes—you heard it on Friday’s webcast (or read it in my notes).

Baraclude and Hepsera cost about $700/month in the U.S. by mail order. I’m expecting (and hoping) NVS/IDIX will price Tyzeka at a slight discount to the competition.

[rsox]

what would fair mkt value for a company like idenix be with a drug like tyzeka ready for mkt. would 4 to 5 times projected sales be too much?